Actively Recruiting
Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety - A Randomized, Sham-Controlled Trial
Led by Shenyang Medical College · Updated on 2026-04-22
56
Participants Needed
1
Research Sites
1 weeks
Total Duration
On this page
Sponsors
S
Shenyang Medical College
Lead Sponsor
T
The Second Hospital of Shenyang Medical College
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to evaluate whether closed-loop functional near-infrared spectroscopy brain-computer interface (fNIRS-BCI) neurofeedback targeting the left dorsolateral prefrontal cortex (DLPFC) can reduce cardiac autonomic arousal during cold-induced pain stress in adults with stable coronary heart disease (CHD) and anxiety disorders. The trial also compares real neurofeedback with sham neurofeedback to study effects on heart rate and brain activation patterns, exploring the link between anxiety and heart function. It is a randomized, sham-controlled, exploratory clinical trial involving adults with confirmed CHD and DSM-5 anxiety disorders. Participants are randomly assigned to either a real neurofeedback group or a sham neurofeedback group. Both groups receive three days of adaptive training sessions involving self-regulation strategies to activate the left DLPFC with visual feedback, slow-wave auditory stimulation, and mild cold-water exposure while electrocardiography (ECG) is recorded. On day 4, participants complete a formal experimental session with 15 blocks of cold-pain stimulation and auditory cues, during which fNIRS and ECG data are recorded simultaneously. The real neurofeedback group receives feedback tightly linked to true brain activation, while the sham group receives feedback minimally coupled to actual brain signals. Participants undergo cardiac and psychiatric screening before enrollment and are monitored for adverse events throughout the trial. Assessments include heart rate changes during the cold-pain task and brain imaging data measuring left DLPFC activation and inter-hemispheric synchronisation. Safety evaluations focus on events related to cardiac function, cold-pain tolerance, and sensor irritation. The study duration includes four days of training and testing, with detailed physiological recordings and statistical analyses to compare effects between groups.
CONDITIONS
Brief Title
Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >18 years, any sex
- Right-handed with resting heart rate between 60 and 100 beats per minute
- Confirmed diagnosis of coronary heart disease by positive stress test, myocardial infarction, or angiographic stenosis 60% in at least one coronary artery
- Diagnosis of an anxiety disorder according to DSM-5
- Hamilton Anxiety Rating Scale score 6 16 and Hamilton Depression Rating Scale score 6 17
You will not qualify if you...
- Acute unstable angina
- Severe congestive heart failure (NYHA class IV)
- Valvular heart disease
- History of atrial fibrillation
- Unstable blood pressure (systolic >180 mmHg or <90 mmHg)
- Pregnancy
- History of unstable medical conditions including cerebrovascular disease, dementia, hyperthyroidism, pulmonary disease, or malignancy
- High risk of suicide or homicide
- Other psychiatric disorders including psychotic disorders, bipolar disorder, or active substance use disorders
- Use of psychotropic medication within 1 month prior to enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 days
Participants practice self-regulation strategies to enhance left dorsolateral prefrontal cortex activation using visual feedback, slow-wave auditory stimulation, and mild cold-water exposure over three sessions.
3 visits (in-person)
Duration - 1 day
Participants complete a single formal experimental session consisting of 15 blocks of rest and stimulation with simultaneous brain and heart monitoring, receiving either real or sham neurofeedback while exposed to auditory and cold-pain stress stimuli.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Second Affiliated Hospital of Shenyang Medical College
Shenyang, Liaoning, China, 110001
Actively Recruiting
Research Team
L
Lin Tao, MM
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here